Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
5.61M
-
Shares change
-
+620K
-
Total reported value, excl. options
-
$98.4M
-
Value change
-
+$11M
-
Put/Call ratio
-
0.61
-
Number of buys
-
38
-
Number of sells
-
-19
-
Price
-
$17.54
Significant Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) as of Q3 2024
78 filings reported holding PLSE - PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share as of Q3 2024.
PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.61M shares
of 69.1M outstanding shares and own 8.12% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.35M shares), VANGUARD GROUP INC (996K shares), BANK OF AMERICA CORP /DE/ (786K shares), STATE STREET CORP (461K shares), GEODE CAPITAL MANAGEMENT, LLC (457K shares), GRIFFIN ASSET MANAGEMENT, INC. (257K shares), NORTHERN TRUST CORP (210K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (148K shares), Nuveen Asset Management, LLC (115K shares), and MORGAN STANLEY (70.2K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.